ATI-0810

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameATI-0810
Drug Alias Nameviral replication inhibitors (University of Arizona)PG-301029ATI-0810
ClassificationSmall molecules
Mechanisms of ActionRNA synthesis inhibitorsVirus replication inhibitors
TargetsUpdating
Therapy Area/IndicationsNeoplasmsHepatitis CHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe University Of Arizona
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesArisyn Therapeutics IncThe University Of Arizona
Active IndicationsN/A
Inactive IndicationsNeoplasmsHepatitis CHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A